- Home
- ATXS vs AIP Comparison
ATXS vs AIP Comparison
Compare ATXS & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- AIP
- Stock Information
- Founded
- ATXS 2008
- AIP 2003
- Country
- ATXS United States
- AIP United States
- Employees
- ATXS N/A
- AIP N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- AIP Semiconductors
- Sector
- ATXS Health Care
- AIP Technology
- Exchange
- ATXS Nasdaq
- AIP Nasdaq
- Market Cap
- ATXS 401.2M
- AIP 290.3M
- IPO Year
- ATXS 2015
- AIP 2021
- Fundamental
- Price
- ATXS $5.34
- AIP $6.91
- Analyst Decision
- ATXS Strong Buy
- AIP Strong Buy
- Analyst Count
- ATXS 5
- AIP 4
- Target Price
- ATXS $26.60
- AIP $12.75
- AVG Volume (30 Days)
- ATXS 276.5K
- AIP 153.6K
- Earning Date
- ATXS 03-11-2025
- AIP 05-01-2025
- Dividend Yield
- ATXS N/A
- AIP N/A
- EPS Growth
- ATXS N/A
- AIP N/A
- EPS
- ATXS N/A
- AIP N/A
- Revenue
- ATXS N/A
- AIP $57,724,000.00
- Revenue This Year
- ATXS N/A
- AIP $19.68
- Revenue Next Year
- ATXS N/A
- AIP $18.13
- P/E Ratio
- ATXS N/A
- AIP N/A
- Revenue Growth
- ATXS N/A
- AIP 7.56
- 52 Week Low
- ATXS $5.29
- AIP $5.76
- 52 Week High
- ATXS $14.04
- AIP $12.64
- Technical
- Relative Strength Index (RSI)
- ATXS 28.85
- AIP 29.19
- Support Level
- ATXS $5.89
- AIP $7.67
- Resistance Level
- ATXS $6.52
- AIP $8.18
- Average True Range (ATR)
- ATXS 0.40
- AIP 0.30
- MACD
- ATXS -0.06
- AIP 0.00
- Stochastic Oscillator
- ATXS 2.50
- AIP 9.93
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About AIP Arteris Inc.
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.